Plantar Fasciitis Randomized Clinical Control Trial

Launched by UNIVERSITY OF PENNSYLVANIA · Jul 24, 2017

Keywords

ClinConnect Summary

This clinical trial is looking to find out which method of injecting corticosteroid is better for relieving pain in people with plantar fasciitis, a common foot condition that causes pain in the heel. Researchers will compare two techniques: ultrasound-guided injection (where imaging helps guide the injection) and anatomic topography-guided injection (which relies on the doctor's knowledge of foot anatomy). They will measure pain relief using a simple pain scale and also look at how foot health and function improve for participants.

To be eligible for this trial, participants should be at least 18 years old and have pain in their heel area, which may or may not be accompanied by a heel spur seen on an X-ray. People with certain health conditions, like severe vascular problems or specific neurological diseases, will not be able to participate. Those who join can expect to receive one of the injection methods and will be monitored for changes in pain and foot function over time. This study is currently recruiting participants of all genders, and it aims to help improve treatment options for plantar fasciitis.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Pain on palpation along the proximal plantar fascia with or without radiographic evidence of a plantar calcaneal bone spur
• • ≥18 years of age
• • Male or non-pregnant female of any ethnicity or race
• • Active, former or non smoker
• • With or without peripheral vascular disease without lower extremity intermittent claudication or rest pain
• • With or without diabetes mellitus without polyneuropathy
• • With or without collagen vascular disease without lower extremity wound formation.
• Exclusion Criteria:
• • Known drug or alcohol dependence
• • Chronic pain syndrome or lumbosacral radiculitis
• • Neurological condition that requires the use of analgesic medications or anti-seizure or neuroleptic medications
• • Peripheral vascular disease that results in rest pain or intermittent claudication or venous stasis ulceration
• • Calcaneal stress fracture or show evidence of a foreign body or tumor of the affected heel as viewed radiographically
• • Pregnant females
• • Known allergy to any of the components of the injection therapy
• • Previously suffered a rupture or surgery of the plantar fascia within the 5 years preceding participation in the investigation
• • Existing or prior osteomyelitis of the involved calcaneus
• • Unable to consent to participation in clinical research or currently be involved in another clinical investigation.